Search filters

List of works by Johan M Kros

-OMICS AND PROGNOSTIC MARKERS

scientific article published on 21 October 2011

1p/19q loss within oligodendroglioma is predictive for response to first line temozolomide but not to salvage treatment.

scientific article published on 17 August 2006

A hypermethylated phenotype is a better predictor of survival than MGMT methylation in anaplastic oligodendroglial brain tumors: a report from EORTC study 26951.

scientific article

Adjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma: long-term follow-up of EORTC brain tumor group study 26951.

scientific article

CLIN-MEDICAL + RADIATION THERAPIES

scientific article published in October 2012

Case report: a fatal combination of hemophagocytic lymphohistiocytosis with extensive pulmonary microvascular damage in COVID-19 pneumonia

scientific article published on 23 October 2020

Cerebral Metastasis of Common Cancers

scientific article published on 29 December 2020

Circulating Proangiogenic Cells and Proteins in Patients with Glioma and Acute Myocardial Infarction: Differences in Neovascularization between Neoplasia and Tissue Regeneration

scientific article published on 21 July 2019

Cytogenetic prognostication within medulloblastoma subgroups

scientific article published on 03 February 2014

Genomic aberrations associated with outcome in anaplastic oligodendroglial tumors treated within the EORTC phase III trial 26951

scientific article

Heterogeneity within the PF-EPN-B ependymoma subgroup

article

Human USP18 deficiency underlies type 1 interferonopathy leading to severe pseudo-TORCH syndrome

scientific article published on 20 June 2016

IDH1 and IDH2 mutations are prognostic but not predictive for outcome in anaplastic oligodendroglial tumors: a report of the European Organization for Research and Treatment of Cancer Brain Tumor Group

scientific article

Improving the characterization of endothelial progenitor cell subsets by an optimized FACS protocol.

scientific article

Intertumoral Heterogeneity within Medulloblastoma Subgroups

scientific article published on June 2017

MGMT promoter methylation is prognostic but not predictive for outcome to adjuvant PCV chemotherapy in anaplastic oligodendroglial tumors: a report from EORTC Brain Tumor Group Study 26951.

scientific article

Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysis

scientific article published on 11 March 2016

Randomized phase II trial of erlotinib versus temozolomide or carmustine in recurrent glioblastoma: EORTC brain tumor group study 26034.

scientific article

Subgroup-specific structural variation across 1,000 medulloblastoma genomes

scientific article

TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma

scientific article published on 31 October 2013

Paulina is supported by:

About Paulina

Help